NB

NB Health Laboratory

1 known investors

nbhl.co.jp ↗

NB Health Laboratory Co. Ltd. (NBHL) develops functional antibodies targeting GPCRs as a new drug modality through its MoGRAA Discovery Engine platform. The company builds GPCR-targeted antibody drug pipelines aimed at clinical application, operating in the biotech and drug discovery sector.

Investors · 1

FA

Fast Track InitiativeTokyo · $1.2M – $184M